TXNIP and cardiac hypertrophy: A recent study by Shi et al. [23] found S. chinensis polysaccharide treatment (50 mg/kg) to prevent cardiac hypertrophy in C57/BL/6 mice (n = 6), possibly by dissociating thioredoxin-interacting protein/thioredoxin-1 complex and reducing oxidative stress.